Keeping Up with the Rapidly Evolving Multiple Sclerosis Treatment Landscape – The Role for Health-System Pharmacists Web Activity

Expert Faculty Presenters:

Mitzi Joi Williams, MD
Joi Life Wellness Group
Click here for biography

Aimee Banks, PharmD, BCPS, MSCS
Clinical Pharmacist, Multiple Sclerosis
Vanderbilt University Medical Center
Click here for biography

Target Audience
This activity is designed to meet the educational needs of pharmacists with an interest managing patients with multiple sclerosis.

Statement of Need/Program Overview
Health care resource utilization associated with MS is significant and continues to rise. The continually evolving MS treatment landscape accentuates the need for increased disease and therapeutic knowledge amongst health-system pharmacy professionals to optimize clinical outcomes, reduce treatment variability, and increase patient engagement in their own care. Increased knowledge and competence will assist health-system pharmacy professionals in delivering quality care to MS patients and improving quality of life throughout the disease course.

Educational Objectives

Accreditation Information

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hours (0.1 CEUs) of the Accreditation Council for Pharmacy Education.

UAN: JA4008162-9999-22-187-H01-P
Activity Type: Application

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy.  PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Expert Faculty Presenters

Reported Financial Relationship

Aimee Banks, PharmD, BCPS, MSCS

Consulting fees (eg. Advisory boards) – Bristol Myers Squibb; EMD Serono; TG Therapeutics

Mitzi Joi Williams, MD

Consulting fees (eg. Advisory boards) – Abbvie, Alexion, Biogen Idec, Bristol Myers Squibb, EMD Serono, Genentech, Novartis, Sanofi Genzyme

Contracted Research – EMD Serono, Genentech, Novartis

The PIM planners and managers have nothing to disclose.
The Impact Education, LLC® planners and managers have nothing to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

In order to obtain your CE certificate, please follow the steps below at the conclusion of the activity:

There is no fee for this educational activity.